new

Get trending papers in your email inbox!

Subscribe

Daily Papers

byAK and the research community

Jan 7

Parallel Scaling Law: Unveiling Reasoning Generalization through A Cross-Linguistic Perspective

Recent advancements in Reinforcement Post-Training (RPT) have significantly enhanced the capabilities of Large Reasoning Models (LRMs), sparking increased interest in the generalization of RL-based reasoning. While existing work has primarily focused on investigating its generalization across tasks or modalities, this study proposes a novel cross-linguistic perspective to investigate reasoning generalization. This raises a crucial question: Does the reasoning capability achieved from English RPT effectively transfer to other languages? We address this by systematically evaluating English-centric LRMs on multilingual reasoning benchmarks and introducing a metric to quantify cross-lingual transferability. Our findings reveal that cross-lingual transferability varies significantly across initial model, target language, and training paradigm. Through interventional studies, we find that models with stronger initial English capabilities tend to over-rely on English-specific patterns, leading to diminished cross-lingual generalization. To address this, we conduct a thorough parallel training study. Experimental results yield three key findings: First-Parallel Leap, a substantial leap in performance when transitioning from monolingual to just a single parallel language, and a predictable Parallel Scaling Law, revealing that cross-lingual reasoning transfer follows a power-law with the number of training parallel languages. Moreover, we identify the discrepancy between actual monolingual performance and the power-law prediction as Monolingual Generalization Gap, indicating that English-centric LRMs fail to fully generalize across languages. Our study challenges the assumption that LRM reasoning mirrors human cognition, providing critical insights for the development of more language-agnostic LRMs.

Coping with Information Loss and the Use of Auxiliary Sources of Data: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions

Clinical trials disruption has always represented a non negligible part of the ending of interventional studies. While the SARS-CoV-2 (COVID-19) pandemic has led to an impressive and unprecedented initiation of clinical research, it has also led to considerable disruption of clinical trials in other disease areas, with around 80% of non-COVID-19 trials stopped or interrupted during the pandemic. In many cases the disrupted trials will not have the planned statistical power necessary to yield interpretable results. This paper describes methods to compensate for the information loss arising from trial disruptions by incorporating additional information available from auxiliary data sources. The methods described include the use of auxiliary data on baseline and early outcome data available from the trial itself and frequentist and Bayesian approaches for the incorporation of information from external data sources. The methods are illustrated by application to the analysis of artificial data based on the Primary care pediatrics Learning Activity Nutrition (PLAN) study, a clinical trial assessing a diet and exercise intervention for overweight children, that was affected by the COVID-19 pandemic. We show how all of the methods proposed lead to an increase in precision relative to use of complete case data only.

  • 12 authors
·
Jun 22, 2022